Johnson & Johnson (NYSE:JNJ) is not only a Dividend Aristocrat, it is also a Dividend King. The 51 Dividend Aristocrats are a group of companies in the S&P 500 Index, with 25+ consecutive years of dividend increases. The Dividend Kings are an even more exclusive group of stocks, with 50+ years of consecutive dividend increases. J&J stock is one of only 22 Dividend Kings. Johnson & Johnson has been in operation for 130 years, and has raised its dividend for 55 years in a row
J&J’s pharmaceutical segment is its strongest area of growth. This segment has generated much higher growth rates than medical devices or consumer products, in recent periods. For example, J&J had adjusted earnings-per-share of $6.73 in 2016, which represented 8% growth from the previous year. Organic revenue increased 7% for 2016. By 2021, J&J expects to file 10 new products, each with annual sales potential of $1 billion or more. It also sees the potential for 40 line extensions to existing products by then. Of these 40 extensions, 10 of which have the potential for more than $500 million in annual revenue.
Source: InvestorPlace
Related Articles:
- 4 Dividend Stocks Delivering The Secret To Successful Investing
- The Magnificent Marvelous Money Machine
- 5 Five-Star Dividend Stocks
- My Top 3 Investing Mistakes
- 6 Stocks Currently Trading Below their Fair Value
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
Owning dividend stocks can be a great way to both generate cash flow and beat the market long term. And if you can find stocks that are over...
-
Long-time readers know I’m a big fan of the insurance industry because of one quirk in their business model. Customers always pay premiums u...
-
I wanted to find an ideal list of stocks with high dividend yields. The stocks would have to be cheap as well. And the dividends would have ...
-
In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those...
-
It has been a glum time for ExxonMobil (NYSE:XOM) shareholders. Regardless of whether you’re looking at the past one year, five years, or te...
-
Investors tend to gravitate to dividend stocks, particularly when those equities increase their payout on an annual basis. When these types ...
-
“Cheap” stocks aren’t necessarily the best cheap stocks to buy. And dividend stocks, even those with a high payout, aren’t necessarily safe....
-
This company's management has raised the quarterly distribution 71 straight quarters, 22 straight years - it will be a Dividend Aristocr...
-
Dividend-paying companies are beacons of profitability. Generally speaking, a company isn't going to share a percentage of its profit or...
-
The markets have been doing very well over the past several weeks, and finding some good bargains has been a bit challenging of late. Howeve...
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.